Cyient DLM Limited (BOM:543933)
939.80
-7.60 (-0.80%)
At close: Oct 6, 2026
Cyient DLM Revenue
Cyient DLM had revenue of 3.74B INR in the quarter ending June 30, 2026, with 34.25% growth. This brings the company's revenue in the last twelve months to 13.57B, down -11.90% year-over-year. In the fiscal year ending March 31, 2026, Cyient DLM had annual revenue of 12.61B, down -16.99%.
Revenue (ttm)
13.57B
Revenue Growth
-11.90%
P/S Ratio
5.49
Revenue / Employee
14.86M
Employees
913
Market Cap
74.54B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2026 | 12.61B | -2.58B | -16.99% |
| Mar 31, 2025 | 15.20B | 3.28B | 27.50% |
| Mar 31, 2024 | 11.92B | 3.60B | 43.25% |
| Mar 31, 2023 | 8.32B | 1.12B | 15.47% |
| Mar 31, 2022 | 7.21B | 925.05M | 14.73% |
| Mar 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Kirloskar Ferrous Industries | 69.62B |
| Genus Power Infrastructures | 51.73B |
| EPL Limited | 50.43B |
| Aditya Vision | 29.24B |
| Mahindra Lifespace Developers | 21.09B |
| Morepen Laboratories | 19.51B |
| Garware Technical Fibres | 16.44B |
| Bliss GVS Pharma | 10.05B |
Cyient DLM News
- 2 months ago - Cyient DLM Transcript: Q1 26/27 - Transcripts
- 2 months ago - Cyient DLM Quarterly report: Q1 2027 - Filings
- 2 months ago - Cyient DLM Slides: Q1 2027 - Filings
- 5 months ago - Cyient DLM Transcript: Q4 25/26 - Transcripts
- 5 months ago - Cyient DLM Quarterly report: Q4 2026 - Filings
- 5 months ago - Cyient DLM Slides: Q4 2026 - Filings
- 5 months ago - Cyient DLM Annual report: Q4 2026 - Filings
- 8 months ago - Cyient DLM Transcript: Q3 25/26 - Transcripts